JPS6237015B2 - - Google Patents
Info
- Publication number
- JPS6237015B2 JPS6237015B2 JP58162084A JP16208483A JPS6237015B2 JP S6237015 B2 JPS6237015 B2 JP S6237015B2 JP 58162084 A JP58162084 A JP 58162084A JP 16208483 A JP16208483 A JP 16208483A JP S6237015 B2 JPS6237015 B2 JP S6237015B2
- Authority
- JP
- Japan
- Prior art keywords
- mycelium
- cane molasses
- culture
- antiviral activity
- brown powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 235000013379 molasses Nutrition 0.000 claims description 23
- 239000003443 antiviral agent Substances 0.000 claims description 11
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 10
- 241000221198 Basidiomycota Species 0.000 claims description 7
- 238000012258 culturing Methods 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 230000000840 anti-viral effect Effects 0.000 description 17
- 239000002609 medium Substances 0.000 description 13
- 239000000843 powder Substances 0.000 description 13
- 239000000243 solution Substances 0.000 description 11
- 241000723873 Tobacco mosaic virus Species 0.000 description 10
- 239000000306 component Substances 0.000 description 9
- 238000012360 testing method Methods 0.000 description 8
- 239000007788 liquid Substances 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 5
- 230000003902 lesion Effects 0.000 description 5
- 241001495644 Nicotiana glutinosa Species 0.000 description 4
- 241000609240 Ambelania acida Species 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 240000000599 Lentinula edodes Species 0.000 description 3
- 239000010905 bagasse Substances 0.000 description 3
- 210000002421 cell wall Anatomy 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 241000712461 unidentified influenza virus Species 0.000 description 3
- 241000724252 Cucumber mosaic virus Species 0.000 description 2
- 240000006499 Flammulina velutipes Species 0.000 description 2
- 235000016640 Flammulina velutipes Nutrition 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 229920002488 Hemicellulose Polymers 0.000 description 2
- 240000001462 Pleurotus ostreatus Species 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 240000000111 Saccharum officinarum Species 0.000 description 2
- 235000007201 Saccharum officinarum Nutrition 0.000 description 2
- 238000010793 Steam injection (oil industry) Methods 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 229920002000 Xyloglucan Polymers 0.000 description 2
- UGXQOOQUZRUVSS-ZZXKWVIFSA-N [5-[3,5-dihydroxy-2-(1,3,4-trihydroxy-5-oxopentan-2-yl)oxyoxan-4-yl]oxy-3,4-dihydroxyoxolan-2-yl]methyl (e)-3-(4-hydroxyphenyl)prop-2-enoate Chemical compound OC1C(OC(CO)C(O)C(O)C=O)OCC(O)C1OC1C(O)C(O)C(COC(=O)\C=C\C=2C=CC(O)=CC=2)O1 UGXQOOQUZRUVSS-ZZXKWVIFSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 229920000617 arabinoxylan Polymers 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 108010089934 carbohydrase Proteins 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 230000035931 haemagglutination Effects 0.000 description 2
- 208000037797 influenza A Diseases 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 210000003292 kidney cell Anatomy 0.000 description 2
- 239000012533 medium component Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 208000035404 Autolysis Diseases 0.000 description 1
- 206010057248 Cell death Diseases 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 208000000419 Chronic Hepatitis B Diseases 0.000 description 1
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 1
- 206010014596 Encephalitis Japanese B Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- 201000005807 Japanese encephalitis Diseases 0.000 description 1
- 241000710842 Japanese encephalitis virus Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 244000168667 Pholiota nameko Species 0.000 description 1
- 235000014528 Pholiota nameko Nutrition 0.000 description 1
- 235000001603 Pleurotus ostreatus Nutrition 0.000 description 1
- 241000606701 Rickettsia Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- UQHKFADEQIVWID-UHFFFAOYSA-N cytokinin Natural products C1=NC=2C(NCC=C(CO)C)=NC=NC=2N1C1CC(O)C(CO)O1 UQHKFADEQIVWID-UHFFFAOYSA-N 0.000 description 1
- 239000004062 cytokinin Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000012317 liver biopsy Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000028043 self proteolysis Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- -1 α-glucidase Proteins 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58162084A JPS6054324A (ja) | 1983-09-05 | 1983-09-05 | 抗ウイルス剤の製造方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58162084A JPS6054324A (ja) | 1983-09-05 | 1983-09-05 | 抗ウイルス剤の製造方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6054324A JPS6054324A (ja) | 1985-03-28 |
| JPS6237015B2 true JPS6237015B2 (enrdf_load_html_response) | 1987-08-10 |
Family
ID=15747776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58162084A Granted JPS6054324A (ja) | 1983-09-05 | 1983-09-05 | 抗ウイルス剤の製造方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6054324A (enrdf_load_html_response) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000065029A1 (en) * | 1999-04-23 | 2000-11-02 | Tsukuba Biosystem, Ltd. | Method for culturing a basidiomycetous fungus in a liquid culture medium |
| KR100424607B1 (ko) * | 2001-06-12 | 2004-03-27 | 주식회사 경기유지 | 옥수수 배아박 또는 ｃｍｓ를 함유하는 버섯 배양배지조성물 |
| KR100424608B1 (ko) * | 2001-06-13 | 2004-03-27 | 주식회사 경기유지 | 고품질의 버섯을 저비용으로 다수확하기 위한 버섯증수개량제 조성물 |
| US9826197B2 (en) | 2007-01-12 | 2017-11-21 | Activevideo Networks, Inc. | Providing television broadcasts over a managed network and interactive content over an unmanaged network to a client device |
| EP2632165B1 (en) | 2007-01-12 | 2015-09-30 | ActiveVideo Networks, Inc. | Interactive encoded content system including object models for viewing on a remote device |
| US9021541B2 (en) | 2010-10-14 | 2015-04-28 | Activevideo Networks, Inc. | Streaming digital video between video devices using a cable television system |
| WO2012138660A2 (en) | 2011-04-07 | 2012-10-11 | Activevideo Networks, Inc. | Reduction of latency in video distribution networks using adaptive bit rates |
| US10409445B2 (en) | 2012-01-09 | 2019-09-10 | Activevideo Networks, Inc. | Rendering of an interactive lean-backward user interface on a television |
| US9800945B2 (en) | 2012-04-03 | 2017-10-24 | Activevideo Networks, Inc. | Class-based intelligent multiplexing over unmanaged networks |
| US9123084B2 (en) | 2012-04-12 | 2015-09-01 | Activevideo Networks, Inc. | Graphical application integration with MPEG objects |
| US10275128B2 (en) | 2013-03-15 | 2019-04-30 | Activevideo Networks, Inc. | Multiple-mode system and method for providing user selectable video content |
| US9326047B2 (en) | 2013-06-06 | 2016-04-26 | Activevideo Networks, Inc. | Overlay rendering of user interface onto source video |
| US9219922B2 (en) | 2013-06-06 | 2015-12-22 | Activevideo Networks, Inc. | System and method for exploiting scene graph information in construction of an encoded video sequence |
| US9294785B2 (en) | 2013-06-06 | 2016-03-22 | Activevideo Networks, Inc. | System and method for exploiting scene graph information in construction of an encoded video sequence |
| US9788029B2 (en) | 2014-04-25 | 2017-10-10 | Activevideo Networks, Inc. | Intelligent multiplexing using class-based, multi-dimensioned decision logic for managed networks |
-
1983
- 1983-09-05 JP JP58162084A patent/JPS6054324A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6054324A (ja) | 1985-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS6237015B2 (enrdf_load_html_response) | ||
| CH641204A5 (fr) | Substance antitumorale obtenue par culture de mycelium. | |
| DE2731570A1 (de) | Verfahren zur gewinnung eines polysaccharids mit therapeutischer wirkung | |
| JPS5939411B2 (ja) | 抗動物ウイルス剤 | |
| US10584311B2 (en) | Method for aseptically culturing fruiting bodies of Antrodia cinnamomea | |
| CN105580638A (zh) | 一种促进牛樟芝液态发酵生长和三萜合成的方法 | |
| Nigam et al. | Cellulase and ligninase production by basidiomycete culture in solid-state fermentation | |
| JP6254569B2 (ja) | 冬虫夏草子実体の人工培養方法及び冬虫夏草を含有する機能性食品 | |
| Severin et al. | Some properties of the curly-top virus | |
| JPS6153033B2 (enrdf_load_html_response) | ||
| Vincent et al. | Duration of invasiveness of Entamoeba histolytica maintained in vitro | |
| US3044940A (en) | Process for enzymatic synthesis of dextran | |
| CA1100867A (en) | Method of inhibiting agricultural and horticultural crop viruses | |
| Parle | The growth of Saccharomycopsis guttulata | |
| JPS60190800A (ja) | フアイトアレキシン誘導物質 | |
| JPS5941302A (ja) | 多糖の製造方法 | |
| JPS5856689A (ja) | 組識培養による地衣成分の生産 | |
| JPS648997B2 (enrdf_load_html_response) | ||
| JPS6070072A (ja) | オタネニンジンの培養法 | |
| JPS5918995B2 (ja) | 多糖類の製造方法 | |
| Caldwell | The physiology of virus diseases in plants | |
| EP0396750A1 (en) | Plant virus controlling agent and process for its preparation | |
| CN112322507A (zh) | 一种类变形被孢霉的菌种培养基及其培养方法 | |
| CN114276973A (zh) | 一种添加牛樟树提取物促进樟芝深层发酵产孢及产糖的方法 | |
| CN115119855A (zh) | 一种防治枣红蜘蛛的生物制剂 |